Cargando…

Taxol: an important new drug in the management of epithelial ovarian cancer.

Taxol, an antineoplastic agent isolated from the Pacific yew, has been demonstrated in three phase 2 clinical trials to have major activity (30 percent overall response rate) in patients with ovarian cancer refractory to cisplatin. The major toxicities associated with the agent are neutropenia (dose...

Descripción completa

Detalles Bibliográficos
Autor principal: Markman, M.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589424/
https://www.ncbi.nlm.nih.gov/pubmed/1687343